Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

mkpatentcrmfinalMarketCRM

Drug Field of development:

Oncology Therapy Area:

Method Type of patent:

Mkpatentcrmfinalmarket

mkpatentcrmfinalMarket […]

BIO16235-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Methods of enhancing the potency of incretin-based drugs in subjects

The present invention relates to methods of enhancing the potency of incretin-based drugs in subjects in need thereof. Through different animal […]

BIO13310-T1

Drug Field of development:

Chronic Heart Failure Therapy Area:

Product Type of patent:

Apelin analogs for the treatment of heart failure

The invention related to metabolically stable Apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin […]

BIO18215-T1

Drug Field of development:

Hematological Disorders Therapy Area:

Product Type of patent:

Methods for increasing fetal hemoglobin content in eukaryotic cells

The clinical severity of β-hemoglobinopathies is alleviated by the co-inheritance of genetic mutations causing a sustained fetal γ-globin chain […]

BIO20503-T1

Drug Field of development:

Hematological Disorders Therapy Area:

Method Type of patent:

Use of il-6 inhibitors for the treatment of acute chest syndrome in

Acute chest syndrome (ACS) is a common and potentially lethal form of acute lung injury in sickle cell disease (SCD). Because pathophysiology remains […]

BIO08404-T1

Drug Field of development:

Myocardial Infarction Therapy Area:

Target Type of patent:

A b cell depleting agent for the treatment of atherosclerosis or post

New anti-atherogenic strategies based on B cell modulation, and suggest that patients currently treated with CD20 antibodies for other immune-mediated […]

BIO19113-T1

Drug Field of development:

Obesity Therapy Area:

Method Type of patent:

Use of an agent capable of inhibiting the activation of mait cells for

Obesity is associated with low-grade inflammation in adipose tissue (AT) and dysfunctional adipocytes producing inflammatory molecules. A recent study […]

BIO15274-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Methods and pharmaceutical compositions for inducing immune tolerance

The present invention relates to methods and pharmaceutical compositions of inducing immune tolerance by mucosal vaccination with Fc-coupled antigens. […]

BIO17684-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Antigenic peptides deriving from pcsk2 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β-cell destruction in type 1 diabetes (T1D), none of their target […]

BIO17685-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β- cell destruction in type 1 diabetes (T1D), none of their target […]

147

56

310

46

Our Technology Offers

Mkpatentcrmfinalmarket

Methods of enhancing the potency of incretin-based drugs in subjects

Apelin analogs for the treatment of heart failure

Methods for increasing fetal hemoglobin content in eukaryotic cells

Use of il-6 inhibitors for the treatment of acute chest syndrome in

A b cell depleting agent for the treatment of atherosclerosis or post

Use of an agent capable of inhibiting the activation of mait cells for

Methods and pharmaceutical compositions for inducing immune tolerance

Antigenic peptides deriving from pcsk2 and uses thereof for the

Antigenic peptides deriving from urocortin 3 and uses thereof for the

You might also be interested in

Mkpatentcrmfinalmarket

Testsynchrotheracrm1904

Cd38 as a biomarker and biotarget in

Methods of enhancing the potency of incretin-based

Apelin analogs for the treatment of heart failure

Monoacylglycerol lipase as target for the

Treatment of bone mineral density related diseases

Methods and compositions for treating skin

Use of coumarin derivatives for the preparation of

Methods and compositions for treating cell

Ctip fusion to cas9 enhances transgene integration

In vitro tests allowing to identify the potential